| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/06/2007 | WO2006110728A3 Immunogenic cmv tegument aggregates |
| 12/06/2007 | WO2006009843A3 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 12/06/2007 | WO2005089231A3 Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide |
| 12/06/2007 | WO2005079515A3 Conformation specific antibodies |
| 12/06/2007 | WO2004052233A3 Canine rankl and methods for preparing and using the same |
| 12/06/2007 | US20070281327 Methods of Screening for Modified Antibodies With Agonistic Activities |
| 12/06/2007 | US20070281006 Methods And Compositions Comprising Supramolecular Constructs |
| 12/06/2007 | US20070280990 Anti-Adhesion Barrier |
| 12/06/2007 | US20070280969 RSF-1 as a prognostic marker and therapeutic target |
| 12/06/2007 | US20070280968 Live Attenuated Bacterial Vaccine |
| 12/06/2007 | US20070280967 Cryo-protective agents for microorganisms |
| 12/06/2007 | US20070280966 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides |
| 12/06/2007 | US20070280965 Encoding anti-BoNT/B antibodies and a tolergizing agent selected from polyethylene glycol, monomethoxypolyethylene glycol and polyvinyl alcohol |
| 12/06/2007 | US20070280964 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis |
| 12/06/2007 | US20070280963 Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors |
| 12/06/2007 | US20070280962 HBV core antigen particles with multiple immunogenic components attached via peptid ligands |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280960 Immunogenic composition comprising genetically engineered poxvirus for monitoring or preventing orbiviruses infection; veterinary medicine |
| 12/06/2007 | US20070280957 Change of the Load State of Mhc Molecules |
| 12/06/2007 | US20070280956 Novel hepatitis C virus peptides and uses thereof |
| 12/06/2007 | US20070280955 Novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
| 12/06/2007 | US20070280954 Novel Immunomodulating Peptide |
| 12/06/2007 | US20070280953 Amyloid beta gene vaccines |
| 12/06/2007 | US20070280952 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 12/06/2007 | US20070280951 Cell Death Inducing Agents |
| 12/06/2007 | US20070280950 Inflammatory Cytokine Inhibitors |
| 12/06/2007 | US20070280949 Combination Therapy for Gastroenteric Diseases Caused by Microorganisms |
| 12/06/2007 | US20070280948 low density lipoprotein receptor-related protein 5 (LRP5) is a cell surface marker for somatic mammary stem cells and mammary tumor stem cells; enriching somatic mammary stem cells by contacting with anti(LRP5) antibody; selecting cells that bind to the antibody |
| 12/06/2007 | US20070280947 Tie Receptor and Tie Ligand Materials and Methods for Modulating Female Fertility |
| 12/06/2007 | US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof |
| 12/06/2007 | US20070280945 Human antibody or antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KD of about <500 pM and blocks IL-6 activity with an IC50 of <200 pM;low dissociation kinetics; pharmakinetics; anticarcinogenic agents; melanoma; antitumor agents; antiarthritis agents; antiinflammatory agents |
| 12/06/2007 | US20070280944 Use of 5,10-Methylene Tetrahydrofolate for the Treatment of Cancer |
| 12/06/2007 | US20070280943 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 12/06/2007 | US20070280942 Compositions and methods for modulating immune responses |
| 12/06/2007 | US20070280941 Vcam-1 specific monoclonal antibody |
| 12/06/2007 | US20070280940 Tweak as a Therapeutic Target for Treating Central Nervous System Diseases Associated with Cerebral Edema and Cell Death |
| 12/06/2007 | US20070280939 Prostatic Acid Phosphatase Antigens |
| 12/06/2007 | US20070280938 Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof |
| 12/06/2007 | US20070280937 Compositions and Methods for the Treatment and Diagnosis of Neoplastic and Infectious Diseases |
| 12/06/2007 | US20070280936 Method for treating psoriasis |
| 12/06/2007 | US20070280935 Antibody that recognizes phosphorylated peptides |
| 12/06/2007 | US20070280934 Compositions and methods for treating cocaine-related disorders |
| 12/06/2007 | US20070280933 Methods for decreasing immune response and treating immune conditions |
| 12/06/2007 | US20070280932 Binding to monoclonal antibodies; antitumor agents |
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | US20070280930 Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury |
| 12/06/2007 | US20070280929 Adjuvant in the form of a lipid-modified nucleic acid |
| 12/06/2007 | US20070280928 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors |
| 12/06/2007 | US20070280927 Treatment Of Neurodegenerative Diseases By The Use Of Atp7a |
| 12/06/2007 | US20070280889 Contrast agent system for x-ray imaging |
| 12/06/2007 | US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same |
| 12/06/2007 | US20070280882 Engineered anti-cd20 antibody fragments for in vivo targeting and therapeutics |
| 12/06/2007 | US20070280881 Dimeric antibody having two antibodies that are non-covalently associated to form a tetravalent antibody dimer having four antigen-biding sites; neoplastic disorders such as colon cancer; autoimmune disorders |
| 12/06/2007 | US20070280879 Therapeutic Use Of Rm1 Antigen |
| 12/06/2007 | US20070279454 Printing apparatus, printing method, and print head |
| 12/06/2007 | CA2653939A1 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 12/06/2007 | CA2653931A1 Immune-derived moieties reactive against lysophosphatidic acid |
| 12/06/2007 | CA2653848A1 Methods of using anti-thymocyte globulin and related agents |
| 12/06/2007 | CA2653661A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | CA2653474A1 Bioactive purified hspe7 compositions |
| 12/06/2007 | CA2653402A1 Method |
| 12/06/2007 | CA2653288A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | CA2652895A1 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 12/06/2007 | CA2652815A1 Methods of treating stroke |
| 12/06/2007 | CA2652049A1 Vaccination of young animals against lawsonia intracellularis infections |
| 12/05/2007 | EP1862550A1 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 12/05/2007 | EP1862549A2 Target of RNAIII activating protein (TRAP) |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862537A1 Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862474A1 Reagent for the diagnosis of rheumatoid arthritis |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 12/05/2007 | EP1862178A1 Use of HLTF antibodies for diagnosis and treatment of cancer |
| 12/05/2007 | EP1862177A1 Method for producing a vaccine composition |
| 12/05/2007 | EP1862176A1 Method for producing a vaccine composition |
| 12/05/2007 | EP1862175A2 Prophylaxis of allergic disease |
| 12/05/2007 | EP1861426A1 Immunogenic molecules |
| 12/05/2007 | EP1861425A2 Anti-mesothelin antibodies |
| 12/05/2007 | EP1861424A2 Human monoclonal antibodies against hendra and pipah viruses |
| 12/05/2007 | EP1861420A1 Fermentation process for the production of diphtheria toxin |
| 12/05/2007 | EP1861418A2 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 12/05/2007 | EP1861123A2 Synergistic efect of tgf-beta blockade and immunogenic agents on tumors |
| 12/05/2007 | EP1861122A1 Composition |
| 12/05/2007 | EP1861121A1 Hiv vaccine composition |
| 12/05/2007 | EP1861120A1 Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response |
| 12/05/2007 | EP1861119A1 Methods of treating or preventing a disease, disorder or condition associated with a viral infection |
| 12/05/2007 | EP1861118A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 12/05/2007 | EP1861117A2 Immunologically active compositions |
| 12/05/2007 | EP1861112A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 12/05/2007 | EP1861096A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 12/05/2007 | EP1860951A2 Porcine helicobacter infection |
| 12/05/2007 | EP1509166B1 Method for improving body weight gain and feed conversion efficiency in animals |
| 12/05/2007 | EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 12/05/2007 | EP0941252B1 Anti-p53 single-chain antibody fragments and their uses |
| 12/05/2007 | EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same |
| 12/05/2007 | CN101084438A B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 12/05/2007 | CN101084042A Novel vaccine for veterinary and human medicine prophylaxis and therapy |
| 12/05/2007 | CN101084015A Antibody formulation in histidine-acetate buffer |